logo

For the Inventor, By the Inventor

Dortmund, Germany

Lead Discovery Center Gmbh

Calculating rank
USPTO Granted Patents = 15

% Expired Patents = 13.3



Forward Citations = 100

Loading Chart...
Loading Chart...

70 inventors (with patents filed for the assignee):

goldMedal Peter Nussbaumer (7 out of 8 patents)

silverMedal Uwe Koch (7 out of 19 patents)

bronzeMedal Jan Eickhoff (7 out of 9 patents)

4.  Gunther Zischinsky (6 out of 10 patents)

5.  Axel Choidas (5 out of 6 patents)

6.  Bert Klebl (5 out of 6 patents)

7.  Tim Bergbrede (4 out of 4 patents)

8.  Kiyean Nam (4 out of 12 patents)

9.  Jaeseung Kim (4 out of 18 patents)

10.  Yeejin Jeon (4 out of 8 patents)

11.  Dongsik Park (4 out of 9 patents)

12.  Raffaella Di Lucrezia (3 out of 3 patents)

13.  Nils-Göran Larsson (3 out of 3 patents)

14.  Maria Falkenberg-Gustafsson (3 out of 3 patents)

15.  Claes M Gustafsson (3 out of 3 patents)


15 patents:

1. 12606561 - Substituted pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitors (2026-04-21),
2. 12281079 - Quinoline derivatives, processes for their preparation and uses thereof for the treatment of cancer (2025-04-21),
3. 12060362 - Inhibitors of glucose transporters (GLUTs) (2024-08-13),
4. 11945822 - Pyrazolo-triazine and/or pyrazolo-pxrimidine derivatives as selective inhibitor of cyclin dependent kinase (2024-04-02),
5. 11858937 - Substituted pyrazolo[1,5-a]pyrimidines and pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitors (2024-01-02),
6. 11111238 - Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer (2021-09-07),
7. 10934274 - Quinoline derivatives as TAM RTK inhibitors (2021-03-02),
8. 10883137 - Method to detect activity of a polymerase (2021-01-05),
9. 10703735 - 4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer (2020-07-07),
10. 9567345 - Pharmaceutically active pyrazolo-triazine derivatives (2017-02-14),
11. 9453051 - Cyclosporin derivatives (2016-09-27),
12. 9242937 - Pharmaceutically active disubstituted pyridine derivatives (2016-01-26),
13. 9096608 - Pharmaceutically active pyrazolo-triazine derivatives (2015-08-04),
14. 8999982 - Pharmaceutically active compounds as Axl inhibitors (2015-04-07),
15. 8084457 - Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases (2011-12-27),
Company Overview
Lead Discovery Center GmbH, based in Dortmund, Germany, specializes in the development of innovative drug discovery solutions. The organization focuses on identifying and advancing novel therapeutic candidates, leveraging cutting-edge technologies in the fields of biochemistry and molecular biology. With a strong emphasis on collaboration, Lead Discovery Center partners with academic institutions and industry players to translate scientific research into viable medical applications, aiming to address unmet medical needs across various therapeutic areas.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Lead Discovery Center Gmbh USPTO Patent Assignee Logo
15 Patents

#19 in Dortmund

#2,777 in Germany

#39,959 in the World

Dortmund, DE
Dortmund, Germany

Lead Discovery Center Gmbh

Forward Citations = 100

70 inventors:

goldMedal Peter Nussbaumer (7 out of 8 patents)

silverMedal Uwe Koch (7 out of 19 patents)

bronzeMedal Jan Eickhoff (7 out of 9 patents)

4.  Gunther Zischinsky (6 out of 10 patents)

5.  Axel Choidas (5 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lead Discovery Center Gmbh. Retrieved from https://idiyas.com/company/lead-discovery-center

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…